Why the study?
Does the CEDIA digoxin immunoassay provide comparable results to the RIA method in measuring serum digoxin concentrations?
Does the CEDIA digoxin immunoassay provide comparable results to the RIA method in measuring serum digoxin concentrations?
The CEDIA digoxin immunoassay is a rapid, stable, and reliable alternative to RIA for measuring serum digoxin levels.
Answers are grounded in this paper and cite their sources.
Supports CEDIA as faster alternative for digoxin monitoring; leaves open need for larger validation before routine use.
We evaluated the CEDIA digoxin immunoassay (Microgenics, Inc., Concord, CA), as performed with the Cobas-Bio centrifugal analyzer. In assays of sera with known concentrations of digoxin, the enzyme activity, measured when two beta-galactosidase (EC 3.2.1.23) fragments were combined according to the assay format, was proportional to the digoxin concentration. Results of assays of sera containing 0 to 3 micrograms of digoxin per liter correlated well when compared with an RIA method: CEDIA, microgram/L = 1.00 x RIA - 0.06 microgram/L (n = 90, r = 0.95, Sxy = 0.05). Duplicate assays of three control sera containing 0.8, 2.2, or 3.3 micrograms/L, each analyzed 20 times a day with each group of patients' samples, gave within-run CVs of 1-3% and day-to-day CVs of 3-12%. The reconstituted CEDIA reagents were stable for at least a month at 5 degrees C. As many as 25 samples and controls can be assayed in half the time needed to complete a similar number of RIA measurements with comparable results.
No takes yet. Share an insight, caveat, or question.
Murthy et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: